Current Oncology (May 2021)

Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience

  • Rami Nassabein,
  • Laura Mansour,
  • Corentin Richard,
  • Franck Vandenbroucke-Menu,
  • Francine Aubin,
  • Jean-Pierre Ayoub,
  • Michel Dagenais,
  • Real Lapointe,
  • Richard Letourneau,
  • Marylène Plasse,
  • André Roy,
  • Simon Turcotte,
  • Mustapha Tehfe

DOI
https://doi.org/10.3390/curroncol28030176
Journal volume & issue
Vol. 28, no. 3
pp. 1899 – 1908

Abstract

Read online

Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with resectable CRLM in our center. We retrospectively analyzed characteristics and outcomes of older patients with CRLM operated at “Centre Hospitalier de l’Université de Montréal” (CHUM) between 2010 and 2019. We identified 210 patients aged ≥70 years with a median age of 76 (range: 70–85). CRLM were synchronous in 56% of patients. Median disease-free survival (DFS) was 41.3 months. Median overall survival (OS) was 62.2 months and estimated 5-year survival rate was 51.5% similar to those of younger counterparts. Patients with metachronous CRLM had a trend to a higher OS compared to those with synchronous disease (67.2 vs. 58.7 months; p = 0.42). Factors associated with lower survival in the multivariate analysis were right-sided tumors and increased Charlson Comorbidity index (CCI). Survival outcomes of patients aged ≥70 years were comparable to those of younger patients and those reported in the literature. Age should not be a limiting factor in the curative management of older patients with resectable CRLM.

Keywords